$23.430
-1.321 (-5.64%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BCAX Prediction & Forecast by Similar Chart Analysis
Alphio's BCAX stock price prediction model matches the current Bicara Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $23.74 (+1.32%). The 1-week path is $23.08 (-1.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bicara Therapeutics Inc Stock?
Bicara Therapeutics Inc is currently priced at $23.43, which is significantly below the average analyst price target of $39, indicating potential upside. However, the stock has an RSI of 34.91, suggesting it is oversold, and a forward P/E of 0, indicating no earnings growth expected in the near term. The company reported a net loss of $55.4 million in Q2 2026, which raises concerns about its financial health. Therefore, while there is potential for price appreciation, the ongoing losses and management changes present significant risks.
BCAX stock price ended at $23.43 on Friday, after losing -5.64%
Bicara Therapeutics Inc (BCAX) last closed at $23.43, losing -5.64%. These facts feed the 1-day and 1-week BCAX price prediction above.
Forecast Drivers
Bicara Therapeutics Inc (BCAX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches BCAX, ranked by similarity.
Seasonality analysis for BCAX
Historically the probability of a positive August return for BCAX is 48.78%. June offers the highest probability of a positive month at 51.22%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BCAX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $7.72 | $9.76 | $11.36 | -58.37% |
| Sep 2026 | $12.02 | $12.89 | $14.96 | -44.98% |
| Oct 2026 | $10.67 | $11.92 | $14.31 | -49.12% |
| Nov 2026 | $7.57 | $9.92 | $10.55 | -57.68% |
| Dec 2026 | $10.44 | $12.80 | $14.55 | -45.37% |
In 2026, Bicara Therapeutics Inc (BCAX) is projected to range from $7.57 to $14.96.
Bicara Therapeutics Inc 2026 monthly forecast
In Aug 2026, Bicara Therapeutics Inc is projected to average $9.76, with a low of $7.72 and high of $11.36.
In Sep 2026, Bicara Therapeutics Inc is projected to average $12.89, with a low of $12.02 and high of $14.96.
In Oct 2026, Bicara Therapeutics Inc is projected to average $11.92, with a low of $10.67 and high of $14.31.
In Nov 2026, Bicara Therapeutics Inc is projected to average $9.92, with a low of $7.57 and high of $10.55.
In Dec 2026, Bicara Therapeutics Inc is projected to average $12.80, with a low of $10.44 and high of $14.55.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.